Latest News about MIRM
Recent news which mentions MIRM
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
From Benzinga
7 Small-Cap Stocks That Get the Nod from Wall Street
October 11, 2023
From InvestorPlace
Why Shares of Travere Therapeutics Are Slumping Thursday
September 21, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
September 20, 2023
From Benzinga
Around $4M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
September 06, 2023
From Benzinga
Raymond James Maintains Strong Buy Rating for Mirum Pharmaceuticals: Here's What You Need To Know
July 18, 2023
Tickers
MIRM
From Benzinga
From Benzinga
Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation
July 17, 2023
From Benzinga
Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 12, 2023
From Benzinga
American Airlines, Cutera, Mirum Pharmaceuticals And Other Big Stocks Moving Lower On Wednesday
April 12, 2023
From Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
From Benzinga
Earnings Scheduled For March 8, 2023
March 08, 2023
From Benzinga
From Benzinga
Mirum Pharmaceuticals's Return On Capital Employed Insights
December 14, 2022
Tickers
MIRM
From Benzinga
Europe Approves Mirum Pharma's Drug For Rare Genetic Liver Disease
December 13, 2022
Tickers
MIRM
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.